Skip to content

Clinical trials

Phase 1 Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20074
20092
20101
20111
20125
20133
20144
20153
20162
20172
20185
20195
20206
20214
20225
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Active, not recruiting12
Terminated4
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Novartis Pharmaceuticals6
Hoffmann-La Roche5
Genentech, Inc.3
Astellas Pharma Inc2
Cancer Research UK2
Daiichi Sankyo2
Eisai Inc.2
Eli Lilly and Company2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms60
Ovarian Neoplasms14
Neoplasms12
Colorectal Neoplasms11
Neoplasm Metastasis11
Carcinoma, Non-Small-Cell Lung10
Prostatic Neoplasms7
Stomach Neoplasms7
Pancreatic Neoplasms6
Squamous Cell Carcinoma of Head and Neck6

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.